Medical researchers at Johns Hopkins aim to accelerate therapies that improve and save lives as liver cancer becomes one of the most common cancers in the U.S.
Nature has long been the source of lifesaving medicines, from willow bark’s natural aspirin to new discoveries in tropical ...
A doctor at an Overland Park hospital made history performing the area's first non-invasive liver tumor treatment.
AZoLifeSciences on MSN
PANoptosis Could Revolutionize Liver Cancer Diagnostics and Treatment
Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the deadliest cancers, driven by high recurrence ...
– Pivotal Phase III IMbrave050 study investigating Tecentriq plus Avastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of ...
Lesions within the same liver responded differently to the same treatment in 40% of cases, with some growing and some shrinking, regardless of the treatment administered.
(RTTNews) - Can-Fite BioPharma Ltd. (CANF) shares are soaring on Monday morning trade after the company announced that the last patient treated under phase II study of Namodenoson hepatocellular ...
From landmark trials leading to new drug approvals to updated clinical practice guidelines, 2024 brought an abundance of pivotal advancements in gastroenterology. Selecting the top 10 must-read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback